An exploratory study of depot-medroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy

被引：3
作者：
Roden, R. Claire [1 ]
Noritz, Garey [2 ,3 ]
McKnight, Erin R. [1 ,2 ]
Bonny, Andrea E. [1 ,2 ,4 ]
机构：
[1] Nationwide Childrens Hosp, Div Adolescent Med, 700 Childrens Dr, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, 370 W 9th Ave, Columbus, OH 43210 USA
[3] Nationwide Childrens Hosp, Div Complex Care, 700 Childrens Dr, Columbus, OH 43205 USA
[4] Nationwide Childrens Hosp, Res Inst, Ctr Clin & Translat Res, 700 Childrens Dr, Columbus, OH 43205 USA
来源：
CONTRACEPTION | 2020年 / 101卷 / 04期
关键词：
Adolescence; Bone mineral density; Disability; Contraception; Depot medroxyprogesterone acetate; Cerebral palsy; CHILDREN; DISABILITY;
D O I：
10.1016/j.contraception.2019.12.009
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Objective: To explore whether use of depot-medroxyprogesterone acetate (DMPA) in adolescent and young adult females with cerebral palsy is associated with lower bone mineral density (BMD). Methods: A chart review of adolescent and young adult females with cerebral palsy who had undergone dual-energy X-ray absorptiometry, comparing BMD among those with (n = 19) and without DMPA (n = 84) exposure. Results: BMD was similar in patients with and without DMPA exposure. All patients had low BMD, with average Z-scores of less than -2 at most sites. Conclusion: Results suggest that DMPA is not associated with lower BMD in non-ambulatory adolescent and young adult females with cerebral palsy. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码：273 / 275
页数：3
相关论文
共 50 条
  • [31] Oral contraceptive use and bone density in adolescent and young adult women
    Scholes, Delia
    Ichikawa, Laura
    LaCroix, Andrea Z.
    Spangler, Leslie
    Beasley, Jeannette M.
    Reed, Susan
    Ott, Susan M.
    CONTRACEPTION, 2010, 81 (01) : 35 - 40
  • [32] Bone density changes in young women in Uganda using tenofovir-based HIV preexposure prophylaxis and depot medroxyprogesterone acetate contraception
    Heffron, Renee
    Muwonge, Timothy R.
    Thomas, Katherine K.
    Zewdie, Kidist
    Ssebuliba, Timothy
    Stein, Gabrielle
    Morrison, Susan
    Badaru, Josephine
    Nakyanzi, Agnes
    Bambia, Felix
    Mugwanya, Kenneth
    Wyatt, Christina
    Matovu, Flavia
    Yin, Michael T.
    Mujugira, Andrew
    AIDS, 2025, 39 (02) : 123 - 132
  • [33] Bone mineral density during long-term treatment with Norplant(R) implants and depot medroxyprogesterone acetate - A cross-sectional study of Thai women
    Taneepanichskul, S
    Intaraprasert, S
    Theppisai, U
    Chaturachinda, K
    CONTRACEPTION, 1997, 56 (03) : 153 - 155
  • [34] Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera®) effects on bone health in adolescents:: study design, population characteristics and baseline bone mineral density
    Johnson, Christine C.
    Burkman, Ronald T.
    Gold, Melanie A.
    Brown, Robert T.
    Harel, Zeev
    Bruner, Ann
    Stager, Margaret
    Bachrach, Laura K.
    Hertweck, S. Paige
    Nelson, Anita L.
    Nelson, Dorothy A.
    Coupey, Susan M.
    McLeod, Alison
    Bone, Henry G.
    CONTRACEPTION, 2008, 77 (04) : 239 - 248
  • [35] Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilizationThe impact oftheboxed warning
    Eworuke, E.
    Popat, V.
    Moeny, D. G.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (04) : 483 - 494
  • [36] The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age
    Gai, Ling
    Zhang, Jinglu
    Zhang, Huizhen
    Gai, Ping
    Zhou, Li
    Liu, Yonghong
    CONTRACEPTION, 2011, 83 (03) : 218 - 222
  • [37] Inadequate Vitamin D Status in Adolescents with Substantial Bone Mineral Density Loss During the Use of Depot Medroxyprogesterone Acetate Injectable Contraceptive: A Pilot Study
    Harel, Z.
    Wolter, K.
    Gold, M. A.
    Cromer, B.
    Bruner, A.
    Stager, M.
    Bachrach, L.
    Hertweck, P.
    Nelson, A.
    Nelson, D.
    Coupey, S.
    Johnson, C. C.
    Burkman, R.
    Bone, H.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2010, 23 (04) : 209 - 214
  • [38] Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use
    Wetmore, C. M.
    Ichikawa, L.
    LaCroix, A. Z.
    Ott, S. M.
    Scholes, D.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) : 519 - 527
  • [39] Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use
    C. M. Wetmore
    L. Ichikawa
    A. Z. LaCroix
    S. M. Ott
    D. Scholes
    Osteoporosis International, 2008, 19 : 519 - 527
  • [40] A pilot study of hormonal contraceptive use and bone mineral density in young women with sickle cell disease
    Harrell, Kristina J.
    Stanek, Joseph
    Bonny, Andrea E.
    Christian-Rancy, Myra
    Creary, Susan E.
    Desai, Payal
    O'Brien, Sarah H.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (12)
12345